ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
7,988.10
-0.32%
S&P ASX All Technology
3,333.70
0.08%
Brent Oil
71.135
-0.56%
US Dollar vs AUD
1.50169
0.17%
Bitcoin
55,535.65
1.24%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE

  6. Emergent Biosolutions Inc (EBS) Share Price

Emergent Biosolutions Inc

Emergent Biosolutions Inc (EBS)

NYSE
7.67
0.15
( 1.99% )
Updated: 23:50:09
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
7.67
Bid
-
Offer
-
Volume
141,789
7.37 Day's Range 7.79
1.42 52 Week Range 15.10
Market Cap
405.794M
Previous Close
7.52
Open
7.44
Last Trade
2
@
7.65
Last Trade Time
23:50:30
Financial Volume
US$ 1,070,159
VWAP
7.5475
Average Volume (3m)
3,290,704
Shares Outstanding
52,906,624
Dividend Yield
-
PE Ratio
-0.54
Earnings Per Share (EPS)
-14.37
Revenue
1.05B
Net Profit
-760.5M

About Emergent Biosolutions Inc

Emergent BioSolutions offers public health products to government and healthcare providers. The company has four main units: vaccines, which produces specialty vaccines for public health threats; devices, such as nasal sprays, skin lotions, and injections; therapeutics, which includes antibody-based... Emergent BioSolutions offers public health products to government and healthcare providers. The company has four main units: vaccines, which produces specialty vaccines for public health threats; devices, such as nasal sprays, skin lotions, and injections; therapeutics, which includes antibody-based treatments; and contract development and manufacturing, which brings treatments to market through collaboration with the pharmaceutical and biotechnology industries and the United States government. Most revenue comes from U.S. government purchases of vaccine, device, and therapeutic products. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.emergentbiosolutions.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Emergent Biosolutions Inc is listed in the Pharmaceutical Preparations sector of the New York Stock Exchange with ticker EBS. The last closing price for Emergent Biosolutions was US$7.52. Over the last year, Emergent Biosolutions shares have traded in a share price range of US$ 1.42 to US$ 15.10.

Emergent Biosolutions currently has 52,906,624 shares in issue. The market capitalisation of Emergent Biosolutions is US$397.86 million. Emergent Biosolutions has a price to earnings ratio (PE ratio) of -0.54.

Ask ADVFN Intelligence (AI)

EBS Latest News

More News

Form 8-K - Current report

03 September 2024
Edgar (US Regulatory)

Emergent BioSolutions Successfully Refinances Debt & Further Strengthens Financial Profile

GAITHERSBURG, Md., Sept. 03, 2024 (GLOBE NEWSWIRE) --  Emergent BioSolutions Inc. (NYSE: EBS) today announced the closing of a new credit facility agreement with Oak Hill Advisors for a term...

03 September 2024
GlobeNewswire Inc.

Emergent BioSolutions Expands Ready to Rescue Initiative to Support Widespread Opioid Emergency Preparedness

For the second year, Emergent is teaming up with pro football legend, Emmitt Smith, to educate communities on opioid risks and how to be prepared with NARCAN® Nasal SprayIn recognition of...

30 August 2024
GlobeNewswire Inc.

Emergent BioSolutions’ ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) Receives U.S. FDA Approval for Mpox Indication; Public Health Mpox Outbreak Continues Across Africa & Other Regions

GAITHERSBURG, Md., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental...

30 August 2024
GlobeNewswire Inc.

Form 8-K - Current report

21 August 2024
Edgar (US Regulatory)

Emergent BioSolutions Finalizes Sale of Baltimore-Camden Manufacturing Site to Bora Pharmaceuticals

GAITHERSBURG, Md., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has completed the sale of its drug product facility in Baltimore-Camden to an...

21 August 2024
GlobeNewswire Inc.

Emergent BioSolutions Responds to Mpox Public Health Emergency as Cases Surge in Africa

Active engagement with the World Health Organization, U.S. government and other global health leaders on critical efforts to prevent mpox disease transmission50,000 doses of ACAM2000®, (Smallpox...

20 August 2024
GlobeNewswire Inc.

Emergent BioSolutions Reports Second Quarter 2024 Financial Results

Second Quarter 2024 Total Revenues of $254.7 million, above the prior guidance rangeSecond Quarter 2024 Net Loss of $283.1 million and Adjusted EBITDA of $(10.1) millionUpdates FY 2024 guidance...

07 August 2024
GlobeNewswire Inc.

Form S-8 - Securities to be offered to employees in employee benefit plans

07 August 2024
Edgar (US Regulatory)

Form 8-K - Current report

07 August 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.73-8.690476190488.48.47.1121495497.45475588CS
40.7310.51873198856.9413.27536.2739550869.47752292CS
121.6727.8333333333615.15.2532907049.31515765CS
264.98185.1301115242.6915.11.820139034725.85904003CS
522.9963.88888888894.6815.11.4231436674.6498665CS
156-52.02-87.150276428259.6959.781.42177106310.80276377CS
260-48.76-86.407939039556.43137.611.42129588023.64201109CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
EEXEmerald Holding Inc
US$ 6.175
(15.21%)
26.45k
BKSYBlackSky Technology Inc
US$ 7.0899
(14.13%)
92.77k
ZWSZurn Elkay Water Solutions Corporation
US$ 33.71
(13.46%)
584.79k
INSPInspire Medical Systems Inc
US$ 221.815
(12.67%)
157.11k
PLTRPalantir Technologies Inc
US$ 33.70
(11.11%)
28.4M
LITBLightInTheBox Holding Co Ltd
US$ 2.41
(-9.06%)
1.1k
LUMNLumen Technologies Inc
US$ 5.46
(-6.51%)
2.45M
AZULAzul SA
US$ 2.17
(-6.47%)
983.11k
NUSNu Skin Enterprises Inc
US$ 7.53
(-5.88%)
226.16k
CLCOCool Company LTD
US$ 10.94
(-5.85%)
103.52k
PLTRPalantir Technologies Inc
US$ 33.7282
(11.20%)
28.44M
NIONIO Inc
US$ 4.925
(-1.89%)
11.55M
DELLDell Technologies Inc
US$ 106.60
(4.51%)
3.95M
SQSPSquarespace Inc
US$ 46.195
(1.98%)
3.44M
TAT&T Inc
US$ 20.97
(0.00%)
3.18M

EBS Discussion

View Posts
Monksdream Monksdream 2 days ago
EBS chart
👍️0
eyeownu eyeownu 4 days ago
added more this will be in double digits in no time. alllllllllllll aboard.
👍️0
allenc allenc 1 week ago
Expect we see a contract for the vaccine soon. $200M in debt reduction, anticipating increase sales of Narcan, this should be a booming Q4 IMO.
👍️ 1
Biggiee Biggiee 1 week ago
https://www.unicef.org/press-releases/unicef-issues-emergency-tender-secure-mpox-vaccines-crisis-hit-countries
👍️0
eyeownu eyeownu 1 week ago
bought 2500 shares today
👍️0
Biggiee Biggiee 1 week ago
Nasty bull trap with that FDA news ah yesterday, but should snap back to double digits when the dark overlords are done playing
👍️0
81vette 81vette 1 week ago
Tutes own 58%,short 3.5m(covering coming)shares to short dropping now,fee rising and rebate dropping,tutes want their shares back before it runs up,patience required on my part isn’t easy lol.
👍️0
Biggiee Biggiee 1 week ago
Loading up now, see you next week!
GLTA
👍️0
Roadtojourney Roadtojourney 1 week ago
What a pos seems like approval was already priced in?? Sell on news??
👍️0
Biggiee Biggiee 2 weeks ago
FDA approval for MPOX
👍️0
Biggiee Biggiee 3 weeks ago
$EBS Rodman & Renshaw initiated coverage of Emergent Biosolutions (NYSE: EBS) with a price target of $16.
👍️0
LEFTY1182 LEFTY1182 3 weeks ago
Soon enough people will catch on with the monkey pox coming! $200+ coming here imo
👍️0
Biggiee Biggiee 3 weeks ago
Why do I bother messaging this board? Talking to myself! Goodnight!
👍️0
Biggiee Biggiee 3 weeks ago
It’s go time once more!
👍️0
Biggiee Biggiee 3 weeks ago
Selling my 9’s here @10.10. Quick flip, I think she goes lower.
GLTA
👍️0
Biggiee Biggiee 3 weeks ago
Sold yesterday, looking for a pullback now to $9’s. Media hasn’t latched on to the crisis fear just yet, we shall see
$EBS
👍️0
81vette 81vette 3 weeks ago
Shares to short dropping,getting excited as word is spreading faster than the virus lol
👍️0
81vette 81vette 3 weeks ago
3.6m short,could squeeze big after hrs
👍️0
Biggiee Biggiee 3 weeks ago
The coming news cycle of “fear the mpox” will do more than just pop. I see a sustained rising trend from here on out. Start looking at the weekly and monthly charts instead of the daily.
$EBS
👍️0
EnchantedTitan62 EnchantedTitan62 3 weeks ago
If they get FDA approval which they are now seeking, it will surely pop again.
👍️0
Biggiee Biggiee 4 weeks ago
It’s go time again, monkey biz
👍️0
Biggiee Biggiee 1 month ago
Yikes! Smoldering crater
👍️0
Biggiee Biggiee 1 month ago
Todays the day! Place your bets for AH
GLtA
👍️0
Biggiee Biggiee 1 month ago
Tree shake! Earnings coming on Aug 6 AH
One to watch $EBS
👍️0
Biggiee Biggiee 1 month ago
Feels like it could be a buy out. Market cap isn’t even a billy, and we are talking about NARCAN! Any guesses above these prices seems like a good bet
👍️0
Sirpeter Sirpeter 1 month ago
How high do you see this going
👍️0
Biggiee Biggiee 2 months ago
F’in beast! $14!
👍️0
Biggiee Biggiee 2 months ago
$13 hit. Such a beast!
👍️0
Biggiee Biggiee 2 months ago
Jumped back in $12.01, I think it’s time to challenge $13
👍️0
Biggiee Biggiee 2 months ago
Looking for the right time to get back in here. $EBS
👍️0
EnchantedTitan62 EnchantedTitan62 2 months ago
Thanks, left some on the table too. I see youve been here for awhile so I'm ' following' ya for any good plays. My picks tend to be long term . Good day sir.
👍️0
Biggiee Biggiee 2 months ago
Nice! Cheers!
👍️0
EnchantedTitan62 EnchantedTitan62 2 months ago
Sold 175 @ 12.05 for $7 gain/share. Not enough to buy a beach house in Cape Cod, but I can buy a plane ticket ! Ha.
👍️0
Biggiee Biggiee 2 months ago
Out 12.20, will jump back in once they finish shaking the tree. Thanks!
👍️0
Biggiee Biggiee 2 months ago
lol, life goes on
👍️0
TrendTrade2016 TrendTrade2016 2 months ago
EBS...TOP IS IN
👍️0
EnchantedTitan62 EnchantedTitan62 2 months ago
Taking a break from chopping wood for the winter. Looks like another day IN THE GREEN. 💲
👍️0
Biggiee Biggiee 2 months ago
Makes sense. The big shorts are leaving the small fries to burn?
👍️0
TrendTrade2016 TrendTrade2016 2 months ago
THE SHORT YESTERDAY WAS ONLY 350 000 AND SHORT COVERING WAS 850 000....IT WAS INTENDED TO LOWER PPS TO COVER
👍️0
Biggiee Biggiee 2 months ago
Short attack failed, see you on the moon
$EBS
👍️0
TrendTrade2016 TrendTrade2016 2 months ago
EBS...HEADED TO MONTHLY TOP BAND
👍️0
EnchantedTitan62 EnchantedTitan62 2 months ago
Up again premarket. Well this retired guy has stuff to do today. Will check on this beautiful 💰💰💰 making machine later today.
👍️0
ANTADOG ANTADOG 2 months ago
12,82 pm, looks like someone nailed it again, yup, ANT
👍️0
EnchantedTitan62 EnchantedTitan62 2 months ago
According to SEC documents, Blackrock as of June 7 2024 still owns over 6,600,000 shares of EBS. Uh, I'm going to continue to hold, they know more than us mere mortals .
👍️0
EnchantedTitan62 EnchantedTitan62 2 months ago
As of March 30th 2024 guess what institution owned the most shares? Ok, got your guess? It's Blackrock with over 7 million shares.
👍️0
EnchantedTitan62 EnchantedTitan62 2 months ago
According to Fintel, 10percent of float is shorted compared to 18percent 3 weeks ago
👍️0
EnchantedTitan62 EnchantedTitan62 2 months ago
🤠👍👍👍
👍️0
luckydude777 luckydude777 2 months ago
Looks to be a better short than long.
👍️0
kindo kindo 2 months ago
Very nice!
👍️0
kindo kindo 2 months ago
Very nice!
👍️0

Your Recent History

NYSE
EBS
Emergent Biosolutions
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved